Lackner Birgit, Pieh Stefan, Schmidinger Gerald, Simader Christian, Franz Carmen, Dejaco-Ruhswurm Irene, Skorpik Christian
Department of Ophthalmology, University of Vienna Medical School, Vienna, Austria.
J Cataract Refract Surg. 2004 Nov;30(11):2269-76. doi: 10.1016/j.jcrs.2004.07.018.
To study the incidence and progression of lens opacification after implantation of phakic posterior chamber intraocular lenses for myopia and its correlation with vaulting and endothelial cell density (ECD).
Department of Ophthalmology, University of Vienna Medical School, Vienna, Austria.
An implantable contact lens (ICL V4, Staar Surgical Inc.) was inserted in 76 myopic eyes. Patients were prospectively followed preoperatively and at 1, 3, 6, 12, 24, and 36 months. The uncorrected visual acuity and best corrected visual acuity (BCVA) were determined. Vaulting was measured optically with a Jaeger II pachymeter, and the crystalline lens was examined at the slitlamp for the presence and characteristics of opacification. Endothelial cell morphometry was performed by specular microscopy, and the ECD was calculated. Eyes in which lens opacification developed were followed for at least 12 months to determine the degree and course of visual impairment.
Lens opacification occurred in 11 eyes (14.5%). Opacification was correlated with intraoperative trauma to the crystalline lens, age older than 50 years, and decreased ECD values throughout the observation period. Vaulting of the ICL did not correlate with the risk for lens opacification. After onset of lens opacification, 6 eyes (55%) had a stable BCVA within +/-0.5 lines and 5 eyes had progressive opacification, losing between 3.5 lines and 0.5 lines (mean 1.8 lines +/- 1.1 [SD]). Three eyes (3.9%) in the progressive group had a 1- to 2-line loss of BCVA over preoperative values and subsequently had cataract surgery.
Risk factors for lens opacification after implantation of the model V4 ICL included intraoperative trauma to the crystalline lens and older age. Decreased ECD in eyes with opacification suggests ongoing inflammation as a cause. Patients younger than 45 years may have a significantly lower incidence of opacification.
研究近视患者植入有晶状体眼后房型人工晶状体后晶状体混浊的发生率及进展情况,及其与房拱高度和内皮细胞密度(ECD)的相关性。
奥地利维也纳医科大学眼科。
对76只近视眼植入可植入式接触镜(ICL V4,STAAR Surgical Inc.)。对患者进行术前及术后1、3、6、12、24和36个月的前瞻性随访。测定未矫正视力和最佳矫正视力(BCVA)。使用耶格II型厚度仪光学测量房拱高度,并在裂隙灯下检查晶状体混浊的存在情况及特征。通过镜面显微镜进行内皮细胞形态测量,并计算ECD。对发生晶状体混浊的眼睛随访至少12个月,以确定视力损害的程度和过程。
11只眼(14.5%)发生晶状体混浊。混浊与术中晶状体损伤、年龄大于50岁以及整个观察期内ECD值降低相关。ICL的房拱高度与晶状体混浊风险无关。晶状体混浊发生后,6只眼(55%)的BCVA在±0.5行内稳定,5只眼有进行性混浊,视力下降3.5行至0.5行(平均1.8行±1.1[标准差])。进行性混浊组中有3只眼(3.9%)的BCVA较术前下降1至2行,随后接受了白内障手术。
植入V4型ICL后晶状体混浊的危险因素包括术中晶状体损伤和年龄较大。混浊眼中ECD降低提示持续炎症是病因。45岁以下患者的混浊发生率可能显著较低。